Cargando…

Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial

BACKGROUND: Patients with advanced oesophageal cancer have a median survival of 3–6 months, and most require intervention for dysphagia. Self-expanding metal stent (SEMS) insertion is the most typical form of palliation in these patients, but dysphagia deterioration and re-intervention are common. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adamson, Douglas, Byrne, Anthony, Porter, Catharine, Blazeby, Jane, Griffiths, Gareth, Nelson, Annmarie, Sewell, Bernadette, Jones, Mari, Svobodova, Martina, Fitzsimmons, Deborah, Nixon, Lisette, Fitzgibbon, Jim, Thomas, Stephen, Millin, Anthony, Crosby, Tom, Staffurth, John, Hurt, Christopher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955283/ https://www.ncbi.nlm.nih.gov/pubmed/33610215 http://dx.doi.org/10.1016/S2468-1253(21)00004-2

Ejemplares similares

Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer Stenting): study protocol for a randomized controlled trial
por: Adamson, Douglas, et al.
Publicado: (2014)

Quality assurance of the SCOPE 1 trial in oesophageal radiotherapy
por: Wills, Lucy, et al.
Publicado: (2017)

Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer
por: Rees, J, et al.
Publicado: (2015)

SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus
por: Hurt, Christopher N, et al.
Publicado: (2011)

The influence of dose distribution on treatment outcome in the SCOPE 1 oesophageal cancer trial
por: Carrington, Rhys, et al.
Publicado: (2016)

Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer
por: Crosby, T, et al.
Publicado: (2017)

Adjuvant statin therapy for oesophageal adenocarcinoma: the STAT‐ROC feasibility study
por: Alexandre, L., et al.
Publicado: (2019)

The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: a radiobiological investigation
por: Carrington, Rhys, et al.
Publicado: (2015)

Coping and wellbeing in bereavement: two core outcomes for evaluating bereavement support in palliative care
por: Harrop, Emily, et al.
Publicado: (2020)

Driving developments in UK oesophageal radiotherapy through the SCOPE trials
por: Gwynne, S., et al.
Publicado: (2019)

The practice of palliative care from the perspective of patients and carers
por: Sampson, Cathy, et al.
Publicado: (2014)

Palliative Care Evidence Review Service (PaCERS): a knowledge transfer partnership
por: Mann, Mala, et al.
Publicado: (2019)

The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy
por: Cox, Samantha, et al.
Publicado: (2017)

Comparison of investigator-delineated gross tumour volumes and quality assurance in pancreatic cancer: Analysis of the on-trial cases for the SCALOP trial
por: Fokas, Emmanouil, et al.
Publicado: (2016)

Neuromuscular Electrical Stimulation of the Quadriceps in Patients with Non-Small Cell Lung Cancer Receiving Palliative Chemotherapy: A Randomized Phase II Study
por: Maddocks, Matthew, et al.
Publicado: (2013)

pROC: an open-source package for R and S+ to analyze and compare ROC curves
por: Robin, Xavier, et al.
Publicado: (2011)

PrimerROC: accurate condition-independent dimer prediction using ROC analysis
por: Johnston, Andrew D., et al.
Publicado: (2019)

Heterodimer formed by ROC8 and ROC5 modulates leaf rolling in rice
por: Xu, Yang, et al.
Publicado: (2021)

Discovery of stable and prognostic CT-based radiomic features independent of contrast administration and dimensionality in oesophageal cancer
por: Piazzese, Concetta, et al.
Publicado: (2019)

Role of nutritional status and intervention in oesophageal cancer treated with definitive chemoradiotherapy: outcomes from SCOPE1
por: Cox, S, et al.
Publicado: (2016)

Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial
por: Mukherjee, Somnath, et al.
Publicado: (2021)

Roc curves for continuous data
por: Krzanowski, Wojtek J, et al.
Publicado: (2009)

Presentation of the “ROC” Chips Readout
por: Dulucq, F, et al.
Publicado: (2009)

Variable Selection in ROC Regression
por: Wang, Binhuan
Publicado: (2013)

Political Status of the ROC in Taiwan
por: Chiang, Frank
Publicado: (2018)

ROC Solid: Receiver Operator Characteristic (ROC) Curves as a Foundation for Better Diagnostic Tests
por: Junge, Mark R. J., et al.
Publicado: (2018)

Model-Based ROC Curve: Examining the Effect of Case Mix and Model Calibration on the ROC Plot
por: Sadatsafavi, Mohsen, et al.
Publicado: (2021)

Health-Related Quality of Life in SCALOP, a Randomized Phase 2 Trial Comparing Chemoradiation Therapy Regimens in Locally Advanced Pancreatic Cancer
por: Hurt, Christopher N., et al.
Publicado: (2015)

Systematic review of the introduction and evaluation of magnetic augmentation of the lower oesophageal sphincter for gastro‐oesophageal reflux disease
por: Kirkham, E. N., et al.
Publicado: (2019)

Conformational heterogeneity of the Roc domains in C. tepidum Roc–COR and implications for human LRRK2 Parkinson mutations
por: Rudi, Katharina, et al.
Publicado: (2015)

Update on Neoadjuvant Regimens for Patients with Operable Oesophageal/Gastrooesophageal Junction Adenocarcinomas and Squamous Cell Carcinomas
por: Cox, Samantha J., et al.
Publicado: (2017)

Gaining an accurate reflection of the reality of palliative care through the use of free-text feedback in questionnaires: the AFTER study
por: Bowyer, Anna Victoria, et al.
Publicado: (2019)

Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trial
por: Mukherjee, Somnath, et al.
Publicado: (2023)

Feasibility RCT of definitive chemoradiotherapy or chemotherapy and surgery for oesophageal squamous cell cancer
por: Blazeby, J M, et al.
Publicado: (2014)

2000 Annual Meeting of the Physical Society of ROC
Publicado: (2000)

Ninth ROC rocks the boat. Report on Carcinogens.
Publicado: (1999)

Use of ROC curves in clinical and experimental studies
por: Polo, Tatiana Cristina Figueira, et al.
Publicado: (2020)

RoCS: Robotic Curriculum for young Surgeons
por: Stockheim, Jessica, et al.
Publicado: (2022)

Understanding how shared decision‐making approaches and patient aids influence patients with advanced cancer when deciding on palliative treatments and care: A realist review
por: Edwards, Michelle, et al.
Publicado: (2023)

ROC Generated Thresholds for Field-Assessed Aerobic Fitness Related to Body Size and Cardiometabolic Risk in Schoolchildren
por: Boddy, Lynne M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6e7q25bb7a0v437tggne8hgthh